Select medical malpractice insurer acquisitions

(Please use a modern browser to see the interactive version of this visualization)

Note: 'Multiple' refers to price-to-reported book value, except for non-public companies (NORCAL, MedMarc, Podiatry), where we have used statutory surplus.

Source: S&P Capital IQ, Insurance Insider US Research